Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.403NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.507NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.178NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.273NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.211NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.474NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AH.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.280NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.72NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.85NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.66 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.72 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.133 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.7 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.33.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.493NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.351.2 (Beta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.640.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.352NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.251NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XCJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FT.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GW.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.367NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.385NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.244NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JD.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.17.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.7.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.10.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KG.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used